Azerbaijan vs Mozambique: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Azerbaijan
52.0%
in 2024
Mozambique
55.0%
in 2024
Azerbaijan rank
139th
Mozambique rank
138th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Azerbaijan
- Mozambique
How they compare
Mozambique currently reports 55.0% against 52.0% in Azerbaijan, a difference of 3.0%.
That makes Mozambique's figure about 1.1 times Azerbaijan's.
Across all 11 years both countries report, Mozambique has been ahead every year.
Azerbaijan ranks 139th and Mozambique ranks 138th of 146 countries.
Mozambique has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.0% | 79.3% | 9.3% | Mozambique |
| 2020s | 50.6% | 57.8% | 7.2% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Azerbaijan or Mozambique?
- Mozambique, at 55.0% against 52.0% in Azerbaijan as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Azerbaijan and Mozambique?
- 3.0%, with Mozambique ahead.
- How many years of comparable data are there for Azerbaijan and Mozambique?
- 11 years are reported by both, from 2014 to 2024.
- How do Azerbaijan and Mozambique rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Azerbaijan ranks 139th and Mozambique ranks 138th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.